Whitehawk Therapeutics (WHWK) Gains from Investment Securities (2015 - 2025)
Whitehawk Therapeutics (WHWK) reported Gains from Investment Securities of $683897.0 for Q2 2025, up 699.91% quarter-over-quarter from -$114000.0 in Q1 2025.
Whitehawk Therapeutics (WHWK) Gains from Investment Securities (2015 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 11 years of Gains from Investment Securities data on file, last reported at $683897.0 in Q2 2025.
- Gains from Investment Securities for Q2 2025 came in at $683897.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$114000.0 (up 56.98% YoY), and the FY2025 annual result was $8.1 million, up 64.05% from the prior year.
- Gains from Investment Securities rose to $683897.0 in Q2 2025 per WHWK's latest filing, from -$114000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.3 million in Q3 2021 and troughed at -$1.6 million in Q4 2022.
- A 5-year average of $59467.9 and a median of -$118000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities jumped 2343.86% in 2021, then sank 218.66% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $1.3 million in 2021, then slumped by 226.84% to -$1.6 million in 2022, then jumped by 92.71% to -$120000.0 in 2023, then slipped by 25.83% to -$151000.0 in 2024, then jumped by 552.91% to $683897.0 in 2025.
- Business Quant data shows WHWK's Gains from Investment Securities at $683897.0 in Q2 2025, -$114000.0 in Q1 2025, and -$151000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 683,897.00 |
| Jun 30, 2025 | 683,897.00 |
| Mar 31, 2025 | -114,000.00 |
| Mar 31, 2025 | -114,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Dec 31, 2023 | -120,000.00 |
| Dec 31, 2023 | -120,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Jun 30, 2023 | -159,000.00 |
| Jun 30, 2023 | -159,000.00 |
| Mar 31, 2023 | -116,000.00 |
| Mar 31, 2023 | -116,000.00 |
| Dec 31, 2022 | -1.65 Mn |
| Dec 31, 2022 | -1.65 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |